# Alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients

**Authors:** Min Wu, Shuo Wang, Keyu Yuan, Bingjun Xiong, Yanping Li, Shuzhen Lyu

PMC · DOI: 10.1186/s12957-024-03454-x · World Journal of Surgical Oncology · 2024-06-27

## TL;DR

This study examines how the immune environment changes in lymph nodes of patients with luminal A breast cancer, finding immune cell patterns linked to metastasis.

## Contribution

The study identifies specific immune cell alterations in axillary lymph nodes that may promote metastasis in luminal A breast cancer.

## Key findings

- PD-1-positive cells were more frequent in early-stage primary tumors compared to advanced-stage ones.
- CD8+ T cells were less frequent in metastatic lymph nodes than in non-metastatic ones.
- CD8+ TIM3+ and CD4+ Foxp3+ T cells were more common in metastatic lymph nodes, suggesting immune suppression.

## Abstract

The alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients is still unclear.

Postsurgical tissues from the enrolled luminal A BCs were divided into five categories: primary BC lesion at stage N0 (PL1), primary BC lesion at stage N1 (PL2), negative axillary lymph node at stage N0 BC (LN1), negative axillary lymph node at stage N1 BC (LN2), and positive axillary lymph node at stage N1 BC (LN3). The frequencies of positive immune markers (CD4, CD8, PD1, PD-L1, T-cell immunoglobulin and mucin domain 3 (TIM3), and forkhead box protein 3 (Foxp3)) in the above tissues were quantified by AKOYA Opal Polaris 7 Color Manual IHC Detection Kit.

A total of 50 female patients with luminal A BC were enrolled in this study. Among these patients, 23 had stage N1 disease, and 27 had stage N0 disease. Compared with that in the PL2 subgroup, the frequency of PD-1-positive cells was significantly greater in the PL1 subgroup, whether at the stromal or intratumoral level (P value < 0.05). Both the frequency of CD8 + T cells in LN1 and that in LN2 were significantly greater than that in LN3 (P value < 0.05). The frequency of TIM3 + T cells in LN1 was significantly greater than that in PL1 (P value < 0.05). The frequency of CD8 + TIM3 + T cells was significantly greater in both the LN2 and LN3 groups than in the PL2 group (P value < 0.05). The frequency of CD4 + Foxp3 + T cells was significantly greater in LN1 than in PL1 (P value < 0.05), which was the same for both LN3 and PL2 (P value < 0.05).

Increased frequencies of CD8 + PD1+, CD8 + TIM3 + and CD4 + Foxp3 + T cells might inhibit the immune microenvironment of axillary metastatic lymph nodes in luminal A breast cancer patients and subsequently promote lymph node metastasis.

## Linked entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920], CD8A (CD8 subunit alpha) [NCBI Gene 925], PDCD1 (programmed cell death 1) [NCBI Gene 5133], CD274 (CD274 molecule) [NCBI Gene 29126], HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868], FOXP3 (forkhead box P3) [NCBI Gene 50943]
- **Diseases:** breast cancer (MONDO:0004989), luminal A breast cancer (MONDO:0021116)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}
- **Diseases:** N0 disease (MESH:D004194), BC lesion (MESH:D009059), lymph node metastasis (MESH:D008207), luminal A breast cancer (MESH:D001943)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11210032/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11210032/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC11210032/full.md

---
Source: https://tomesphere.com/paper/PMC11210032